Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie Hiltbrunner

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncoimmunology|December 20, 2013
Potentiating antitumor immunity with αGC-loaded exosomesUlf Gehrmann, Stefanie Hiltbrunner, Tanja I Näslund, et al.
Seminars in Cancer Biology|May 27, 2014
Harnessing the exosome-induced immune response for cancer immunotherapyUlf Gehrmann, Tanja I Näslund, Stefanie Hiltbrunner, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 27, 2015
Designer exosomes as next-generation cancer immunotherapyBrandon M Bell, Isabel D Kirk, Stefanie Hiltbrunner, et al.
Plos One|May 3, 2011
HVEM signalling promotes colitisCorinne Schaer, Stefanie Hiltbrunner, Bettina Ernst, et al.
Cancer Research|May 10, 2013
Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomesUlf Gehrmann, Stefanie Hiltbrunner, Anna-Maria Georgoudaki, et al.
British Journal of Cancer|September 22, 2022
Genomic landscape of pleural and peritoneal mesothelioma tumoursStefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2019
Allogenicity Boosts Extracellular Vesicle-Induced Antigen-Specific Immunity and Mediates Tumor Protection and Long-Term Memory In VivoPia Larssen, Rosanne E Veerman, Gözde Güçlüler Akpinar, et al.
Scientific Reports|December 8, 2017
Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivoCasper J E Wahlund, Gözde Güclüler, Stefanie Hiltbrunner, et al.
Clinical Lung Cancer|July 3, 2019
Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer RecurrenceMax Lacour, Stefanie Hiltbrunner, Seok-Yun Lee, et al.
Oncotarget|May 28, 2016
Exosomal cancer immunotherapy is independent of MHC molecules on exosomesStefanie Hiltbrunner, Pia Larssen, Maria Eldh, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncoimmunology|December 20, 2013
Potentiating antitumor immunity with αGC-loaded exosomesUlf Gehrmann, Stefanie Hiltbrunner, Tanja I Näslund, et al.
Seminars in Cancer Biology|May 27, 2014
Harnessing the exosome-induced immune response for cancer immunotherapyUlf Gehrmann, Tanja I Näslund, Stefanie Hiltbrunner, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 27, 2015
Designer exosomes as next-generation cancer immunotherapyBrandon M Bell, Isabel D Kirk, Stefanie Hiltbrunner, et al.
Plos One|May 3, 2011
HVEM signalling promotes colitisCorinne Schaer, Stefanie Hiltbrunner, Bettina Ernst, et al.
Cancer Research|May 10, 2013
Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomesUlf Gehrmann, Stefanie Hiltbrunner, Anna-Maria Georgoudaki, et al.
British Journal of Cancer|September 22, 2022
Genomic landscape of pleural and peritoneal mesothelioma tumoursStefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2019
Allogenicity Boosts Extracellular Vesicle-Induced Antigen-Specific Immunity and Mediates Tumor Protection and Long-Term Memory In VivoPia Larssen, Rosanne E Veerman, Gözde Güçlüler Akpinar, et al.
Scientific Reports|December 8, 2017
Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivoCasper J E Wahlund, Gözde Güclüler, Stefanie Hiltbrunner, et al.
Clinical Lung Cancer|July 3, 2019
Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer RecurrenceMax Lacour, Stefanie Hiltbrunner, Seok-Yun Lee, et al.
Oncotarget|May 28, 2016
Exosomal cancer immunotherapy is independent of MHC molecules on exosomesStefanie Hiltbrunner, Pia Larssen, Maria Eldh, et al.
Pageof 3